C57BL/6JCya-Slc32a1em1/Cya
Common Name
Slc32a1-KO
Product ID
S-KO-16935
Backgroud
C57BL/6JCya
Strain ID
KOCMP-22348-Slc32a1-B6J-VA
When using this mouse strain in a publication, please cite “Slc32a1-KO Mouse (Catalog S-KO-16935) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Slc32a1-KO
Strain ID
KOCMP-22348-Slc32a1-B6J-VA
Gene Name
Product ID
S-KO-16935
Gene Alias
VGAT, Viaat
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
Chr 2
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000045738
NCBI RefSeq
NM_009508.2
Target Region
Exon 2
Size of Effective Region
~3.3 kb
Overview of Gene Research
Slc32a1, also known as the vesicular inhibitory amino acid cotransporter (VGAT), is a gene that encodes the only protein identified to date that loads gamma-aminobutyric acid (GABA) and glycine into synaptic vesicles, thus playing a crucial role in inhibitory neurotransmission. GABAergic neurotransmission is essential for regulating neuronal excitability in the nervous system [2].
Missense variants in Slc32a1 have been associated with genetic epilepsy with febrile seizures plus (GEFS+) and idiopathic generalized epilepsy (IGE). These variants are predicted to alter GABA transport into synaptic vesicles, leading to altered neuronal inhibition [1]. De novo missense variants in Slc32a1 can also cause a developmental and epileptic encephalopathy. In silico modeling and functional analyses in a murine neuronal cell culture model showed that some variants reduce quantal size, consistent with impaired filling of synaptic vesicles with GABA, while another variant increases presynaptic release probability, leading to more severe synaptic depression during high-frequency stimulation [2]. Conditional deletion of MOR-encoding Oprm1 in Vgat+ (Slc32a1-expressing) neurons abolished morphine-induced itch, suggesting that spinal inhibitory interneurons expressing Slc32a1 are involved in the itch-related disinhibition mechanism [3].
In conclusion, Slc32a1 is essential for proper inhibitory neurotransmission by facilitating the loading of GABA into synaptic vesicles. Studies using mouse models, especially those with gene variants or conditional knockouts related to Slc32a1, have revealed its significance in epilepsy and encephalopathy, as well as in the context of morphine-induced itch. These findings contribute to understanding the underlying mechanisms of these neurological and pain-related conditions.
References:
1. Heron, Sarah E, Regan, Brigid M, Harris, Rebekah V, Gécz, Jozef, Berkovic, Samuel F. 2021. Association of SLC32A1 Missense Variants With Genetic Epilepsy With Febrile Seizures Plus. In Neurology, 96, e2251-e2260. doi:10.1212/WNL.0000000000011855. https://pubmed.ncbi.nlm.nih.gov/34038384/
2. Platzer, Konrad, Sticht, Heinrich, Bupp, Caleb, Abou Jamra, Rami, Wojcik, Sonja M. 2022. De Novo Missense Variants in SLC32A1 Cause a Developmental and Epileptic Encephalopathy Due to Impaired GABAergic Neurotransmission. In Annals of neurology, 92, 958-973. doi:10.1002/ana.26485. https://pubmed.ncbi.nlm.nih.gov/36073542/
3. Wang, Zilong, Jiang, Changyu, Yao, Hongyu, Huh, Yul, Ji, Ru-Rong. . Central opioid receptors mediate morphine-induced itch and chronic itch via disinhibition. In Brain : a journal of neurology, 144, 665-681. doi:10.1093/brain/awaa430. https://pubmed.ncbi.nlm.nih.gov/33367648/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
